FDA Pre-Approval Of Commercial Speech: “Coming Soon” To DTC Device Ads?
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is urging FDA to consider a pre-approval policy for direct-to-consumer advertising within the Center for Devices & Radiological Health
You may also be interested in...
CDRH More Reliant On SEC, FTC For Ad/Promotion Vigilance Under Policy Shift
The Center for Devices & Radiological Health increasingly is looking to other federal agencies to help regulate medical device advertising and promotion as it scales back its own claim enforcement activities
CDRH More Reliant On SEC, FTC For Ad/Promotion Vigilance Under Policy Shift
The Center for Devices & Radiological Health increasingly is looking to other federal agencies to help regulate medical device advertising and promotion as it scales back its own claim enforcement activities
McClellan Reinforces FDA Advertising Surveillance, Warning Letter Policy
FDA remains committed to its vigilant oversight of direct-to-consumer advertising following a request for expedited handling of DTC ad warning letters by the General Accounting Office